×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Tango Therapeutics Inc. (TNGX) NASDAQ

$11.06 (0.67) (-5.71%)

Market Cap: $1.20B

As of 02/21/24 04:00 PM EST. Market closed.

(TNGX)

Tango Therapeutics Inc. (TNGX)
NASDAQ

$11.06
(0.67) (-5.71%)

Market Cap: $1.20B

As of 02/21/24 04:00 PM EST. Market closed.

Add to Portfolio

tango therapeutics is a biotechnology company discovering and developing novel medicines targeting cancer vulnerabilities to deliver transformational new therapies for patients. tango was launched in 2017 with a $55 million series a investment from third rock ventures. the company has established a robust product engine that leverages advances in dna sequencing and crispr-based target discovery ... read more

tango therapeutics is a biotechnology company discovering and developing novel medicines targeting cancer vulnerabilities to deliver transformational new therapies for patients. tango was launched in 2017 with a $55 million series a investment from third rock ventures. the company has established a robust product engine that leverages advances in dna sequencing and crispr-based target discovery to generate breakthrough medicines that have the potential to provide deeper, more sustained benefit than today’s targeted therapies, and extend the benefit of available immuno-oncology agents. tango therapeutics is focused on three areas of drug development, each in well-defined patient populations currently lacking effective treatment options, and each with hallmarks of cancer that have not been targeted yet. these include: loss of tumor suppressor gene function; multiple oncogenic drivers; and immune evasion. what fuels each of tango’s programs is an increasingly sophisticated ability to util read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
129
Address
.
PRICE CHART FOR TANGO THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$11.60
Previous Close
$11.73
Days Range
$11.69 - $12.10
52 week range
$2.47 - $13.03
Volume
644,079
Avg. Volume (30 days)
574,854
Market Cap
$1.20B
Dividend Yield
-
P/E
(11.96)
Shares Outstanding
101,989,696
Open
$11.60
Previous Close
$11.73
Days Range
$11.69 - $12.10
52 week range
$2.47 - $13.03
Volume
644,079
Avg. Volume (30 days)
574,854
Market Cap
$1.20B
Dividend Yield
-
P/E
(11.96)
Shares Outstanding
101,989,696
FINANCIAL STATEMENTS FOR TANGO THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR TANGO THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Third Rock Ventures IV, L.P.10% OwnerFeb 20, 2024 Sale$12.00162,5001,950,00019,201,475Feb 21, 2024, 05:52 PM
Weber BarbaraChief Executive OfficerFeb 07, 2024 Sale$12.624,45756,2461,535,167Feb 08, 2024, 09:14 PM
Weber BarbaraChief Executive OfficerFeb 06, 2024 Sale$12.564,68158,8061,539,624Feb 08, 2024, 09:14 PM
Barry DouglasGeneral CounselFeb 07, 2024 Sale$12.621,35417,08743,981Feb 08, 2024, 09:09 PM
Barry DouglasGeneral CounselFeb 06, 2024 Sale$12.561,42217,86445,335Feb 08, 2024, 09:09 PM
Beckman DaniellaChief Financial OfficerFeb 06, 2024 Sale$12.561,90823,969134,214Feb 08, 2024, 09:08 PM
Beckman DaniellaChief Financial OfficerFeb 07, 2024 Sale$12.621,81722,930132,397Feb 08, 2024, 09:08 PM
Crystal AdamSee RemarksFeb 07, 2024 Sale$12.624,08351,527119,478Feb 08, 2024, 09:04 PM
Crystal AdamSee RemarksFeb 06, 2024 Sale$12.564,28853,868123,561Feb 08, 2024, 09:04 PM
Crystal AdamSee RemarksNov 01, 2023 Sale$8.397,50762,99481,250Nov 02, 2023, 04:49 PM
Boxer Capital, LLCSee remarksOct 16, 2023 Buy$6.84500,0003,420,0008,198,642Oct 17, 2023, 07:41 PM
Boxer Capital, LLCSee remarksOct 13, 2023 Buy$7.07750,0005,302,5007,698,642Oct 17, 2023, 07:41 PM
Boxer Capital, LLCSee remarksOct 13, 2023 Buy$7.07750,0005,302,5007,698,642Oct 17, 2023, 06:04 PM
Boxer Capital, LLCSee remarksOct 16, 2023 Buy$6.84500,0003,420,0008,198,642Oct 17, 2023, 06:04 PM
Boxer Capital, LLCSee remarksOct 09, 2023 Sale$9.97175,0001,744,7506,948,642Oct 11, 2023, 09:22 PM
Boxer Capital, LLCSee remarksOct 09, 2023 Sale$9.9150,000495,500693,524Oct 11, 2023, 09:22 PM
Boxer Capital, LLCDirectorAug 11, 2023 Option Exercise$5.15475,0002,446,250743,542Oct 11, 2023, 07:22 PM
Boxer Capital, LLCSee remarksAug 11, 2023 Buy$5.15475,0002,446,250743,542Aug 15, 2023, 09:34 PM
Boxer Capital, LLC10% OwnerOct 12, 2022 Buy$4.4350,000221,640268,524Oct 13, 2022, 09:30 PM
Boxer Capital, LLC10% OwnerOct 11, 2022 Buy$4.25117,000497,706218,524Oct 13, 2022, 09:30 PM
Boxer Capital, LLC10% OwnerOct 13, 2022 Buy$4.6570,000325,2277,123,642Oct 13, 2022, 09:30 PM
Boxer Capital, LLC10% OwnerOct 06, 2022 Buy$4.0670,394286,0677,053,642Oct 06, 2022, 09:15 PM
Boxer Capital, LLC10% OwnerOct 05, 2022 Buy$3.8886,000334,0536,983,248Oct 06, 2022, 09:15 PM
Boxer Capital, LLC10% OwnerOct 04, 2022 Buy$3.6725,60693,9776,897,248Oct 06, 2022, 09:15 PM
BCTG Holdings, LLC10% OwnerNov 20, 2020 Sale$0.015,000304,490,950Nov 24, 2020, 09:30 PM
BCTG Holdings, LLC10% OwnerSep 08, 2020 Buy$10.00533,5005,335,0004,493,450Sep 10, 2020, 07:33 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Third Rock Ventures IV, L.P.10% Owner02/20/20241,950,000
Weber BarbaraChief Executive Officer02/07/202456,246
Weber BarbaraChief Executive Officer02/06/202458,806
Barry DouglasGeneral Counsel02/07/202417,087
Barry DouglasGeneral Counsel02/06/202417,864
Beckman DaniellaChief Financial Officer02/06/202423,969
Beckman DaniellaChief Financial Officer02/07/202422,930
Crystal AdamSee Remarks02/07/202451,527
Crystal AdamSee Remarks02/06/202453,868
Crystal AdamSee Remarks11/01/202362,994
Boxer Capital, LLCSee remarks10/16/20233,420,000
Boxer Capital, LLCSee remarks10/13/20235,302,500
Boxer Capital, LLCSee remarks10/13/20235,302,500
Boxer Capital, LLCSee remarks10/16/20233,420,000
Boxer Capital, LLCSee remarks10/09/20231,744,750
Boxer Capital, LLCSee remarks10/09/2023495,500
Boxer Capital, LLCDirector08/11/20232,446,250
Boxer Capital, LLCSee remarks08/11/20232,446,250
Boxer Capital, LLC10% Owner10/12/2022221,640
Boxer Capital, LLC10% Owner10/11/2022497,706
Boxer Capital, LLC10% Owner10/13/2022325,227
Boxer Capital, LLC10% Owner10/06/2022286,067
Boxer Capital, LLC10% Owner10/05/2022334,053
Boxer Capital, LLC10% Owner10/04/202293,977
BCTG Holdings, LLC10% Owner11/20/202030
BCTG Holdings, LLC10% Owner09/08/20205,335,000
Load More Insider Transactions
FUNDS WITH A POSITION IN TANGO THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.3,949,2760.001%11.01%Other
ADAGE CAPITAL PARTNERS GP, L.L.C.3,400,0000.07%93.75%Other
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)1,540,0000.28%94.02%Other
GEODE CAPITAL MANAGEMENT, LLC1,097,1020.00114%6%Other
BALYASNY ASSET MANAGEMENT L.P.844,3770.02%ExitedEvent Driven
BAKER BROS. ADVISORS LP750,0000.08%No changeOther
RENAISSANCE TECHNOLOGIES LLC121,0000.00185%216.75%Other
FISHER ASSET MANAGEMENT, LLC100,6910.00049%NewOther
TUDOR INVESTMENT CORP ET AL52,1050.00415%NewEvent Driven, Other
AQR CAPITAL MANAGEMENT LLC22,1760.00041%NewOther
D. E. SHAW & CO., INC.15,4130.00013%NewOther
CHANGE IN SHARES OUTSTANDING FOR TANGO THERAPEUTICS INC
STOCK BUYBACKS FOR TANGO THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
9.82%
1Q
09/30/2023
03/31/2023
10.02%
2Q
09/30/2023
12/31/2022
10.67%
3Q
09/30/2023
09/30/2022
10.40%
4Q
09/30/2023
06/30/2022
10.47%
5Q
09/30/2023
03/31/2022
10.68%
6Q
09/30/2023
12/31/2021
56.23%
7Q
09/30/2023
09/30/2021
38.30%
8Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
9.82%
1Q
03/31/2023
10.02%
2Q
12/31/2022
10.67%
3Q
09/30/2022
10.40%
4Q
06/30/2022
10.47%
5Q
03/31/2022
10.68%
6Q
12/31/2021
56.23%
7Q
09/30/2021
38.30%
8Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR TANGO THERAPEUTICS INC
LOADING...